Assessing Real World Efficacy, Safety, and 18-Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies.

Chemaly N, Kuchenbuch M, Losito E, Kaminska A, Coste-Zeitoun D, Barcia G, Desguerre I, Hully M, Nabbout R

DOI: 10.1111/ene.70304
Published: 2025 Sep
Container: European journal of neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ene.70304,
  title = {Assessing Real World Efficacy, Safety, and 18-Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies.},
  author = {Chemaly N and Kuchenbuch M and Losito E and Kaminska A and Coste-Zeitoun D and Barcia G and Desguerre I and Hully M and Nabbout R},
  year = {2025},
  journal = {European journal of neurology},
  doi = {10.1111/ene.70304},
  url = {https://doi.org/10.1111/ene.70304}
}

RIS

TY  - JOUR
TI  - Assessing Real World Efficacy, Safety, and 18-Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies.
AU  - Chemaly N
AU  - Kuchenbuch M
AU  - Losito E
AU  - Kaminska A
AU  - Coste-Zeitoun D
AU  - Barcia G
AU  - Desguerre I
AU  - Hully M
AU  - Nabbout R
PY  - 2025
JO  - European journal of neurology
DO  - 10.1111/ene.70304
UR  - https://doi.org/10.1111/ene.70304
ER  -

APA

N, C., M, K., E, L., A, K., D, C., G, B., I, D., M, H., & R, N. (2025). Assessing Real World Efficacy, Safety, and 18-Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies.. European journal of neurology. https://doi.org/10.1111/ene.70304

Source records

pubmed · retrieved 2026-09-26T12:41:12.823Z